Identification of anti‐α‐enolase autoantibody as a novel serum marker for endometriosis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Diagnosis of endometriosis needs invasive maneuvers. New serum marker that possesses both high sensitivity and high specificity has long been desired. To establish novel serum marker for endometriosis, serum autoantibodies (autoAbs) were investigated using proteomic approach. AutoAbs in sera of endometriotic patients and healthy controls were analyzed using a mesothelial cell line, 2‐DE and Western blotting. Proteins in reacted spots were identified using MALDI TOF‐MS with MASCOT analysis. ELISAs were established using recombinant proteins and autoAb‐titers were estimated in sera of endometriotic patients, disease and healthy controls. Several autoAbs were identified. Anti‐α‐enolase (Eno1)‐autoAb levels in endometriotic patients were significantly elevated compared with both healthy and disease controls. Sensitivity and specificity of serum anti‐Eno1‐autoAb was nearly comparable to serum CA125. When anti‐Eno1‐autoAb and CA125 assays were combined, diagnostic sensitivity and accuracy improved. Serum anti‐Eno1‐autoAb can be a new serum endometriotic marker and it is useful as a supplement assay for CA125. This study validates further clinical evaluation of this novel marker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Endometriosis: cost estimates and methodological perspective
Simoens, S., Hummelshoj, L., & D'Hooghe, T. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm010 · Cited by 357
Endometriosis and Infertility: Epidemiology and Evidence‐based Treatments
Ozkan, S., Murk, W., & Arici, A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1434.007 · Cited by 347
Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?
Matarese, G., De Placido, G., Nikas, Y., & Alviggi, C. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00051-0 · Cited by 315
Zhang, H., Niu, Y., Feng, J., Guo, H., Ye, X., & Cui, H. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.028 · Cited by 101 · cited 1×
“However, Eno1 was not found in that study [21].”
Background
Cited by
Blood biomarkers for the non-invasive diagnosis of endometriosis
Nisenblat, V., Bossuyt, P. M., Shaikh, R., Farquhar, C., Jordan, V., Scheffers, C. S., Mol, B. W. J., Johnson, N., & Hull, M. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012179 · Cited by 376
Urinary vitamin D-binding protein is elevated in patients with endometriosis
Cho, S., Choi, Y. S., Yim, S. Y., Yang, H. I., Jeon, Y. E., Lee, K. E., Kim, H., Seo, S. K., & Lee, B. S. (2012) · Human Reproduction · doi:10.1093/humrep/der345 · Cited by 74
Identification and validation of novel serum markers for early diagnosis of endometriosis
Gajbhiye, R., Sonawani, A., Khan, S., Suryawanshi, A., Kadam, S., Warty, N., Raut, V., & Khole, V. (2012) · Human Reproduction · doi:10.1093/humrep/der410 · Cited by 53
Noninvasive biomarkers of endometriosis: myth or reality?
Lanišnik Rižner, T. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.899905 · Cited by 52
Investigation of diagnostic potentials of nine different biomarkers in endometriosis
Ozhan, E., Kokcu, A., Yanik, K., & Gunaydin, M. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.04.037 · Cited by 44
Metadata
- Authors
- Nabeta, M., Abe, Y., Kagawa, L., Haraguchi, R., Kito, K., Ueda, N., Sugita, A., Yokoyama, M., Kusanagi, Y., & Ito, M.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2009-10
- Volume
- 3
- Issue
- 10
- Pages
- 1201-1210
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2122883290
- Cited by
- 32
- References
- 5
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.